Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simrit Parmar

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|September 13, 2015
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell TransplantationSyed M Kazmi, Maliha Nusrat, Hilal Gunaydin, et al.
Bone Marrow Transplantation|October 20, 2018
Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantationMithun Vinod Shah, Rima M Saliba, Gabriela Rondon, et al.
Cancer|September 30, 2016
Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myelomaIdrees Mian, Denái R Milton, Nina Shah, et al.
American Journal of Hematology|August 30, 2017
Clinical outcomes in adult patients with aplastic anemia: A single institution experiencePrajwal Boddu, Guillermo Garcia-Manero, Farhad Ravandi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2012
Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcomeYago Nieto, Uday Popat, Paolo Anderlini, et al.
American Journal of Hematology|January 25, 2013
Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control studyElias Jabbour, Michael S Mathisen, Guillermo Garcia-Manero, et al.
Cancer|September 3, 2011
A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acidManish Sharma, Hassan Khan, Peter F Thall, et al.
NEJM Evidence|April 22, 2025
Clinical Safety and Preliminary Efficacy of Regulatory T Cells for ALSNeil A Shneider, Alex V Nesta, Olivia M Rifai, et al.
Blood|August 31, 2006
Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitorsTony A Navas, Mani Mohindru, Myka Estes, et al.
British Journal of Haematology|January 22, 2013
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantationFleur M Aung, Benjamin Lichtiger, Roland Bassett, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Clinical Lymphoma, Myeloma & Leukemia|September 13, 2015
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell TransplantationSyed M Kazmi, Maliha Nusrat, Hilal Gunaydin, et al.
Bone Marrow Transplantation|October 20, 2018
Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantationMithun Vinod Shah, Rima M Saliba, Gabriela Rondon, et al.
Cancer|September 30, 2016
Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myelomaIdrees Mian, Denái R Milton, Nina Shah, et al.
American Journal of Hematology|August 30, 2017
Clinical outcomes in adult patients with aplastic anemia: A single institution experiencePrajwal Boddu, Guillermo Garcia-Manero, Farhad Ravandi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2012
Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcomeYago Nieto, Uday Popat, Paolo Anderlini, et al.
American Journal of Hematology|January 25, 2013
Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control studyElias Jabbour, Michael S Mathisen, Guillermo Garcia-Manero, et al.
Cancer|September 3, 2011
A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acidManish Sharma, Hassan Khan, Peter F Thall, et al.
NEJM Evidence|April 22, 2025
Clinical Safety and Preliminary Efficacy of Regulatory T Cells for ALSNeil A Shneider, Alex V Nesta, Olivia M Rifai, et al.
Blood|August 31, 2006
Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitorsTony A Navas, Mani Mohindru, Myka Estes, et al.
British Journal of Haematology|January 22, 2013
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantationFleur M Aung, Benjamin Lichtiger, Roland Bassett, et al.
Pageof 12